You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 129 No. 2, February 1994 TABLE OF CONTENTS
  Archives
  •  Online Features
  Papers
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Interferon Gamma Administration Increases Monocyte HLA-DR Antigen Expression but Not Endogenous Interferon Production

David H. Livingston, MD; Patricia A. Loder, RN, MS; Susan M. Kramer, DrPH; Ursula E. M. Gibson, MS; Hiram C. Polk, Jr, MD

Arch Surg. 1994;129(2):172-178.


Abstract

Objective
To determine the effect of the adjuvant administration of interferon gamma on monocyte HLA-DR antigen expression and mitogen-stimulated interferon gamma production following injury.

Design
Double-blind, randomized, placebocontrolled trial.

Setting
University Hospital, Newark, NJ, a level I trauma center.

Patients
Persons older than 16 years with an Injury Severity Score greater than 20 and documented bacterial contamination at the time of injury (N=98).

Interventions
Recombinant human interferon gamma (n=46; 0.1 mg subcutaneously) or placebo (n=52) was given for 10 days following injury.

Outcomes
Incidence of major infection, monocyte and lymphocyte cell surface antigen expression, and interferon gamma production at multiple time points following injury.

Results
Peripheral monocyte HLA-DR was measured as percent of cells staining positive and as mean channel fluorescence. Both values were significantly increased in the interferon gamma group compared with the placebo group on days 3, 5, 8, and 11. The incidence of major infection was unaffected by interferon gamma administration. Infection decreased percent of HLA-DR—positive monocytes and mean channel fluorescence as compared with noninfected patients on postinjury days 8 and 11 in the placebo group but not in the interferon gamma group. Interferon gamma production improved from 3±3 U/mL on day 1 to 15 ±10 U/mL by day 30 but was always significantly lower than normal (25±3 [mean±SD] U/mL). Interferon gamma production was unaffected by either infection or interferon gamma administration.

Conclusions
Interferon gamma administration after injury stimulated monocyte HLA-DR antigen expression and density but failed to improve interferon gamma production, a T-cell—mediated function. The incidence of infection was not decreased by the administration of interferon gamma for 10 days. Improvement in monocyte HLA-DR antigen expression did not correlate with a global restoration of immune function, and other interventions will be necessary to decrease infection after injury.

(Arch Surg. 1994;129:172-178)



Author Affiliations

From the Departments of Surgery, UMD—New Jersey Medical School, Newark, NJ (Dr Livingston and Ms Loder), and University of Louisville (Ky) (Dr Polk) and Genentech Inc, South San Francisco, Calif (Dr Kramer and Ms Gibson).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Gamma Interferon Does Not Enhance Clearance of Pseudomonas aeruginosa but Does Amplify a Proinflammatory Response in a Murine Model of Postseptic Immunosuppression
Murphey et al.
Infect. Immun. 2004;72:6892-6901.
ABSTRACT | FULL TEXT  

Interferon-{gamma} increases monocyte HLA-DR expression without effects on glucose and fat metabolism in postoperative patients
de Metz et al.
J. Appl. Physiol. 2004;96:597-603.
ABSTRACT | FULL TEXT  

Interferon-{gamma} counteracts reduced endotoxin responsiveness of whole blood following trauma and cardiopulmonary bypass
Flohe et al.
Innate Immunity 2000;6:431-436.
ABSTRACT  

Interferon-gamma has immunomodulatory effects with minor endocrine and metabolic effects in humans
de Metz et al.
J. Appl. Physiol. 1999;86:517-522.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.